Related Experiment Videos
Molecular markers of carcinogenesis
1Division of Environmental Health Sciences, School of Public Health, Columbia University, New York, NY 10032, USA.
Pharmacology & Therapeutics
|May 13, 1998
Summary
Detecting oncogene and tumor suppressor gene proteins in blood offers potential as cancer biomarkers. These molecular markers could aid in early cancer diagnosis, prognosis, and prevention strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Oncogenes and tumor suppressor genes are crucial in cancer development.
- Their protein products are often detectable in bodily fluids like blood.
- This presents an opportunity for non-invasive cancer detection.
Purpose of the Study:
- To review literature on detecting oncogene and tumor suppressor gene proteins in human blood.
- To explore the utility of these proteins as cancer biomarkers.
- To assess their potential role in cancer diagnosis, prognosis, and prevention.
Main Methods:
- Literature review of studies detecting specific cancer-related proteins in blood.
- Analysis of methods used for protein detection in extracellular fluids.
- Compilation of data on the association between protein levels and cancer status.
Main Results:
- The expression of certain oncogene and tumor suppressor gene proteins is detectable in blood.
- These proteins show promise as indicators of carcinogenesis.
- Detection methods are being refined for clinical application.
Conclusions:
- Blood-based detection of oncogene and tumor suppressor gene proteins represents a significant advancement.
- These molecular markers hold potential for improving cancer diagnosis, prognosis, and prevention.
- Further research can validate their clinical utility.